Liana Hayrapetyan: The impact of radiation therapy in combination with DNA-PKcs Inhibition in head and neck cancer
Liana Hayrapetyan, MD-PhD at University of Bern, shared on LinkedIn:
“I’m excited to share one of the projects I worked on during my PhD at the Universität Bern! The paper is now published in Molecular Cancer Therapeutics!
In this study, we investigated the impact of radiation therapy in combination with DNA damage repair pathway inhibition in head and neck cancer models. Our findings reveal that HPV status and p53 protein expression are critical in determining treatment outcomes in our experimental models. These factors may help shape the potential benefits of this treatment strategy in specific patient populations.
For more details, check out the paper. A big thanks to all my coauthors, collaborators, and supervisors!”
Authors: Liana Hayrapetyan, Selina M. Roth, Aurélie Quintin, Lusine Hovhannisyan, Matúš Medo, Rahel Riedo, Julien G. Ott, Joachim Albers, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023